Ross is a partner in the Corporate Technology team, based in our Cambridge office.

Ross’s practice focuses on helping tech and life sciences companies in all aspects of their growth, capital raising and international expansion. He has extensive experience of a variety of venture financing and public capital raisings, mergers and acquisitions and general corporate advice, with a particular specialism in transactions with a transatlantic component.

Ross has extensive experience of transactions involving the US and was based out of San Francisco, CA in 2018 - 19. As a result, he has a particular expertise in supporting US investors and companies in their investment into the UK and elsewhere, as well as counselling UK companies looking to take investment from, or exit to, the US. He is an English qualified solicitor and registered foreign legal consultant in California.

Ross is the co-author of PLC’s leading article on M&A pricing structures: Pricing Mechanisms: locked box vs completion accounts.

显示完整简历 隐藏完整简历

最新新闻和观点

技术、媒体与通信 (TMC)

Advising Telensa on its acquisition by Signify

2022年1月27日

作者 Ross McNaughton

点击此处了解更多
酒店与休闲

Conference series widens investor access to cutting-edge healthcare stocks

2022年1月18日

作者 Ross McNaughton

点击此处了解更多
公司/并购与资本市场

Advising Cambridge Epigenetix on its $88 million Series D funding round to advance best-in-class DNA sequencing technology platform

2021年11月2日

作者 Ross McNaughton 以及 Oli Denne

点击此处了解更多
公司/并购与资本市场

Advising AI-powered personalisation provider Qubit on its acquisition by Coveo

2021年11月1日

作者

点击此处了解更多

与我会面: